Vazyme goes public on Shanghai Stock Exchange today
PR93046
NANJING, China, Nov. 15, 2021 /PRNewswire=KYODO JBN/ --
On November 15, 2021, Nanjing Vazyme Biotech Co., Ltd. (Vazyme) went public on
the STAR MARKET of the Shanghai Stock Exchange under the stock code 688105.
Founded in Nanjing in 2012, Vazyme develops technologies and products related
to functional proteins including enzymes, antigens and antibodies as well as
organic polymer materials. Relying on its proprietary critical generic
technology platform, the company has successively entered business areas
including biological research, in vitro diagnosis and biomedicine. Vazyme is
one of the few innovative R&D companies with both independent and controllable
upstream technology development and final product manufacturing capabilities in
China. The company owns more than 200 kinds of genetic engineering recombinases
and 1,000 kinds of high-performance antigens and monoclonal antibodies. In
addition, Vazyme has over 500 final products that have wide applications in
scientific research, high-throughput sequencing, in vitro diagnosis,
pharmaceutical and vaccine development as well as animal quarantine, among
other fields.
Backed by many years of experience in the molecular biological reagent segment,
Vazyme has strong R&D and product iteration capabilities, a perfected technical
system and a well-established marketing network. Looking ahead, the
publicly-listed company plans to accelerate its roadmap for an expanded
presence in global markets, with the expectation of contributing to the ongoing
development of the world's biotechnology sector.
At the ceremony celebrating the firm's success at listing on the Shanghai Stock
Exchange, Vazyme chairman and founder Cao Lin said, "Today's listing is of
great significance to Vazyme. We have worked on obtaining this listing for
nearly 10 years, in this period we made our full efforts and experienced all
kinds of hardships. Vazyme will strictly comply with each and every one of the
requirements and rules for listed companies, constantly enhance our management,
communicate regularly with investors and maintain the transparency of our
company, as part of our mission to give back to society and the shareholders by
way of sustained growth and better performance."
SOURCE: Vazyme
Image Attachments Links:
Link: http://asianetnews.net/view-attachment?attach-id=407513
Caption: Vazyme goes public on Shanghai Stock Exchange today
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。